The financing round is led by J2 Ventures’ involvement in Bain Resources Ventures and Lightspeed Endeavor Allies.
The business places tools compatibility and purchase obstacles right into aid-supported medical care production.
Zinit’s system targets the “tail investing” section, representing 30% and 80% of the acquisition worth.
Investors in this round of financing include Sumitomo Corporation, SMBC Venture Capital and Mitsubishi UFJ Capital.
The business places tools compatibility and purchase obstacles right into aid-supported medical care production.
Zinit’s system targets the “tail investing” section, representing 30% and 80% of the acquisition worth.
Sign in to your account